Method of priming a dialysis machine
Abstract
A method and apparatus of priming or rinse back of an extracorporeal circuit using a dialysis machine comprising a dialysis liquid preparation system. The dialysis machine is used to prepare a saline solution on-line. The extracorporeal circuit is connected to the dialysis machine and primed with the saline solution.

Term
Term ended
Expired 22 November 2022, 3.8 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
12 claims: 7 independent, 5 dependent
- 1A method of priming an extracorporeal circuit using a dialysis machine comprising a dialysis liquid preparation system having, a source (10, 11, 12) of water, separate sources (20, 15) of bicarbonate concentrate and sodium chloride concentrate, said extracorporeal circuit comprises an arterial line (80), connectable to a patient, for drawing blood from the patient, a venous line (70), connectable to the patient, for returning the blood to the patient, and a blood side compartment (51) of a dialyser, said method comprising the steps of:- preparing a saline solution from said source (10, 11, 12) of water and said source (15) of sodium chloride to obtain a saline liquid/solution, wherein bicarbonate is absent from the saline solution, - connecting said arterial line (80) to an outlet of the dialysis liquid preparation system of the dialysis machine and, - filling the extracorporeal circuit with said saline liquid/solution.
- 10Method according any of the proceeding claims, further comprising the step of providing an indication that the dialysis machine is ready for filling said extracorporeal circuit.
- 11Method according any of the proceeding claims, in which the saline solution is substantially physiological with a sodium ion concentration about 154 mmol/l.
Independent claims7
37 paragraphs in 5 sections, as filed
TECHNICAL FIELD
The present invention relates to a method of priming of an extracorporeal circuit using a dialysis machine, which prepares a saline solution for priming.
BACKGROUND ART
Physiological saline solution (about 9mg/ml=154 mmol/l) is typically used to prime the extra corporeal circuit before a dialysis patient is connected to the dialysis equipment and to rinse back the blood from the extracorporeal circuit after a dialysis treatment. The purpose of priming the circuit is to remove air from the blood lines and the dialyser as well as to remove possible fragments of remaining sterilising agents or other residuals from the disposables elements, such as bloodlines and dialysers that form the extracorporeal circuit, before the patient is connected. Rinse back is performed to avoid loss of patient blood that would otherwise remain in the extracorporeal circuit.
The conventional way of doing this is to use for instance a 2 liters bag of physiological saline solution of which 1.5 liters is used for priming of the circuit and 0.5 liters is used for rinse back of the blood to the patient after the treatment.
Modem dialysis equipment can perform so called on-line treatments, which means that the substitution fluid for hemofiltration or hemodiafiltration is prepared on-line by means of ultrafiltration of dialysis fluid in several steps to obtain a sterile and pyrogen free fluid,
On-line prepared substitution fluid can be prepared in practically unlimited quantities which means that this fluid also can be used for priming, bolus and rinse back purposes which also is cost saving and convenient from a handling point of view.
However, substitution fluid has to contain a high concentration of bicarbonate. Infusing priming liquid with this volume and composition into the patient often causes problems, e.g. not well feeling. This problem is known from "Gambro AK 200 ULTRA<sup>™</sup> operator's manual HCEN9568. Rev 12.1999 and cautioned for in all on-line systems. Clinics experiencing such problems often go back to priming with saline from bags.
There is therefore a long felt need for a simple, cheap and practical manner of providing a priming solution.
<patcit id="pcit0001" dnum="US6635026B"><text>US 6 635 026</text></patcit> discloses a hemofiltration machine that comprises a solution generator for preparing a first injectable solution from at least one concentrated solution. The document also reveals the priming of the injection circuit with the first solution.
<patcit id="pcit0002" dnum="DE3442744"><text>DE 34 42 744</text></patcit> discloses a dialysis machine with a device for re-use of hemodialysers.
<patcit id="pcit0003" dnum="US5259961A"><text>US 5 259 961</text></patcit> discloses a method and assembly for the on-line flushing and filling of an extracorporeal blood circulation system of dialysis machines.
DISCLOSURE OF THE INVENTION
On this background, it is the object of the present invention to provide a method of priming an extracorporeal circuit of the kind referred to initially, which overcomes the above-mentioned problem. This object is achieved in accordance with claim 1 by using a dialysis machine with separate sources of bicarbonate concentrate and sodium chloride concentrate and means to prepare a mix of the liquids from said source of water and said source of sodium chloride concentrate to obtain a saline solution and filling said extracorporeal circuit with said saline solution
According to an embodiment of the invention the sodium chloride concentrate is prepared by dissolving solid sodium chloride in water. Preferably the arterial line is connected to the dialysis machine through an infusion line which preferably includes an ultrafilters.
According to another embodiment the saline solution comprises minor amounts of other electrolytes and other components for the dialysis liquid, such as potassium, calcium, magnesium, glucose with or without acid such as citric acid, hydrochloric acid and acetic acid. In yet another embodiment, the water from said source of water and/or said saline solution is passed through one or more ultrafilters for removal of bacteria and endotoxins.
Advantageously an indication that the dialysis machine is ready for filling said extracorporeal circuit is provided. Preferably, the saline solution is substantially physiological with a sodium ion concentration about 154 mmol/l.
A dialysis machine that is capable of preparing a saline solution in accordance with the invention has separate sources of bicarbonate concentrate and sodium chloride concentrate and means to prepare a mix of the liquids from said source of water and said source of sodium chloride concentrate to obtain a saline solution.
Such a dialysis machine comprises in one embodiment a conductivity cell downstream of said mixing point. Preferably, the dialysis machine further comprises means to adjust the mixing ratio of said water and said sodium chloride concentrate, preferably in response to a signal from the conductivity cell.
The dialysis machine further comprises an infusion line connected to the outlet of the dialysis machine, said infusion line preferably including an ultrafilter. Preferably, the dialysis machine further comprises at least one ultrafilter in the flow path of said water.
Further objects, features, advantages and properties of the method according to the invention will become apparent from the detailed description.
BRIEF DESCRIPTION OF THE DRAWINGS
In the following detailed portion of the present description, the invention will be explained in more detail with reference to exemplary embodiments. <figref idref="f0001">Figure 1</figref> is a schematic diagram of a dialysis machine that is capable of performing the method according to the invention.
DETAILED DESCRIPTION
The general term dialysis as used here includes hemodialysis, hemofiltration, hemodiafiltration and therapeutic plasma exchange (TPE), among other similar treatment procedures. The general term dialyzer as used here includes hemofilters and hemodiafilters amongst other similar devices.
The general term saline solution as used here includes any solution comprising saline, preferably a substantially physiological saline solution. In general, solutions comprising saline, described as substantially physiological saline solutions, are approved by the health and/or regulatory authorities in the country in which they are used. Therefore, these saline solutions comprising saline may differ somewhat in their composition in different countries, but a physiologically acceptable saline solution is always a solution that is physiological acceptable used, or when administered to a patient. An example of an acceptable physiological saline may be a solution comprised of about 0.85% salt and distilled water; this solution approximately, therefore, being equal to the salt content of blood serum and thereby able to maintain normal osmotic pressure in the body. The term saline solution as used here also includes in any solution containing minor amounts of other electrolytes and other components such as those normally used in preparing for the dialysis liquid, and can include, for example, potassium, calcium, magnesium, glucose and/or acid, as long as the solution remains substantially physiological: a typical solution with a sodium ion concentration may contain, for example, about 154 mmol/l. Deviations from this concentration in the range of 150 to 158 mmol/l are tolerable.
In <figref idref="f0001">figure 1</figref>, a dialysis machine is shown including a dialyser 50 having two compartments 51 and 52 that are separated by a semipermeable membrane 54. The compartment 51 is connected to a circuit for convening a flow of blood outside the body of a patient comprising an upstream duct 80, usually referred to as arterial line, having a peristaltic pump 84 disposed therein, and a downstream duct 70, usually referred to as venous line. Venous line 70 is provided with a bubble trap 74 and the free ends of the ducts of the arterial and venous lines can be fitted respective needles or catheter connections to enable them to be connected to the vascular circuit of a patient.
The dialysis machine comprises a system for preparing dialysis fluid from dialysate fluid concentrate and/or powder including a heating reservoir 10 having an inlet 12 for water from for example a reverse osmosis unit. An ultra filter 11 is placed between the water inlet 12 and the tank 10. A dry powder vessel 20 containing bicarbonate is disposed in duct 21. A part of the water in the heating reservoir 10 is flown through the vessel 20 by a precisely controlled pump 22. Thus, a saturated bicarbonate solution is obtained from the vessel 20, and mixed into a main duct 5 at mixing point 17.
The dialysis fluid preparation system further comprises a duct 23 for preparing sodium chloride concentrate. A dry powder vessel 15 containing sodium chloride is disposed in duct 23. A part of the water in the heating reservoir 10 is flown through the vessel 15 by a precisely controlled pump 16. Pump 16 is connected to the vessel 15 by a duct 14. Thus, a saturated sodium chloride solution is obtained from the vessel 15 and mixed into the main duct 5 at mixing point 7.
The remaining electrolytes used in dialysis fluid, e.g. potassium, calcium, magnesium, and other substances such as glucose and acid are added into duct 5 at mixing point 7 by withdrawing a concentrate solution containing from a small bag or canister 26 by means of a metering pump 28 in duct 31.
Pumps 16, 22 and 28 are controlled by a control unit 58. Downstream of mixing points 7 and 17 conductivity cells 9 and 19 monitor the conductivity change caused by the introduction of the respective electrolytes in the main duct 5. The signal of the respective conductivity cell is in a closed loop manner compared with the expected conductivity determined by the control unit 58. When the actual conductivity differs from the expected the control unit 58 adjusts the respective pump 16 and 22 in order to arrive at the correct conductivity and composition of the dialysate fluid.
The main duct includes a pump 8 and in normal dialysis operation (not shown) directs the dialysate fluid to an inlet of compartment 52 of the dialyser 50. During normal dialysis operation, an outlet of the compartment 52 is connected to a downstream duct 61 having an extraction pump 64 disposed therein for establishing variable suction inside the compartment 52. The duct 61 leads to a waste liquid (ultrafiltrate and/or processed dialysis liquid) container 67. Duct 5 leading to compartment 52 and duct 61 leading away from compartment 52 both pass a flow rate cell 40.
The dialysis machine is provided with input means 59 allowing an operator to select a mode of operation in which the dialysis machine prepares a saline or a saline like solution. In this mode of operation pumps 22 and 28 are not operated. The conductivity set value for the conductivity cell 9 downstream of mixing point 7 is set to a value corresponding to a solution having a sodium chloride concentration of 154 mmol/l and pump 16 is controlled accordingly.
For priming the extracorporeal circuit, an infusion line 44 is connected to the main duct 5. The main duct 5 comprises a second ultrafilter 48. The infusion line 44 includes another ultrafilter 46 for ensuring the sterility of the fluid delivered. There are thus three ultrafilters in series to guarantee sufficient sterile quality of the priming fluid by removing bacteria and endotoxins. Fewer ultrafilters may be used, however with an increased risk of insufficient sterility of the replacement fluid. The infusion line 44 is primed with the saline solution and then the infusion line is connected to the arterial bloodline 80 by connector 85 and the priming of the extracorporeal circuit begins. The venous bloodline 70 is typically connected to a waste bag 73 or another type of drain connection.
Once the extracorporeal circuit is sufficiently primed, the patient can be connected. According to a preferred embodiment, the control unit 58 of the dialysis machine is connected to a sensor (not shown) that detects the presence of blood in the extracorporeal blood circuit. The control unit 58 adjusts the settings of the pumps 16, 22 and 28 and the conductivity cells 9 and 19 to values for preparing dialysate fluid with a composition in accordance with the settings of the operator. The usual setting for sodium ions is for instance 140 mmol/l and the usual setting for bicarbonate ions is 34 mmol/l.
After the treatment is completed, the infusion line is connected to the arterial bloodline again whilst the venous bloodline remains connected to the patient (not shown) the control unit 58 sets the pumps 16, 22 and 28 for preparing a saline solution and by means of pump 8 the saline solution is transported into the extracorporeal circuit to rinse back the patient blood.
According to a preferred embodiment, the saline solution is produced by mixing sodium chloride concentrate coming from vessel 15 and the concentrate of vessel 26 with the water in the main duct 5. The resulting saline solution will, apart from sodium chloride, contain some minor amounts of other electrolytes and some acid, but this does not pose any problem for the patients.
According to a preferred embodiment, chamber 52 of the dialyser is also filled with the saline solution. Hereto chamber 52 is connected to the main duct 5 as in the dialysis treatment (not shown), and the saline solution is pumped into chamber 52.
Before beginning the preparation of the saline solution, the vessel 15 containing sodium chloride in dry form, is primed by drawing water in from heating vessel 10 though activation of pump 16. Line 31 is primed by running pump 28 at high speed until a fluid flow is detected. The vessel 20 containing sodium bicarbonate does not have to be primed until the patient is connected. If it is primed anyway before the saline preparation has started, the main duct 5 is rinsed from bicarbonate before the saline preparation begins.
The vessels 15 and 20 containing the electrolytes in dry form do not necessarily have to be cartridges as shown in the accompanying drawings. Bags, or any other kind of containers are equally suitable.
The fluid preparation system does not have to be based on the use of a flow rate cell 40. The present invention will operate also with fluid preparation systems using the balance chamber principle.
Further it has been shown above to start with sodium chloride in dry form. Of course, it is also possible to use sodium chloride concentrate instead.
Contents5
1 sheet
Sheet 1
Every citation, both waysCites: the store holds 26 of 27
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO2020109038A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| EP4005613A1 | Cited by | European Patent Office (EPO) | Search report |
| US11931493B2 | Cited by | United States of America | Applicant |
| WO02098491A1 | Cites | World Intellectual Property Organization (WIPO) | Opposition |
| EP0560368A2 | Cites | European Patent Office (EPO) | Opposition |
| EP0992255A2 | Cites | European Patent Office (EPO) | Opposition |
| US2001037968A1 | Cites | United States of America | Opposition |
| DE60037233T2 | Cites | Germany | Opposition |
| US6132616A | Cites | United States of America | Opposition |
| DE7309462U | Cites | Germany | Opposition |
| US7387734B2 | Cites | United States of America | Opposition |
| WO9920376A1 | Cites | World Intellectual Property Organization (WIPO) | Opposition |
| EP0192588A1 | Cites | European Patent Office (EPO) | – |
| EP0278100A2 | Cites | European Patent Office (EPO) | – |
| EP0560368A2 | Cites | European Patent Office (EPO) | – |
| EP0992255A2 | Cites | European Patent Office (EPO) | – |
| EP1097724A2 | Cites | European Patent Office (EPO) | – |
| WO9920376A1 | Cites | World Intellectual Property Organization (WIPO) | – |
| WO9930756A1 | Cites | World Intellectual Property Organization (WIPO) | – |
| WO02098491A1 | Cites | World Intellectual Property Organization (WIPO) | – |
| DE3442744A | Cites | Germany | – |
| DE60037233T2 | Cites | Germany | – |
| DE7309462U1 | Cites | Germany | – |
| US5259961A | Cites | United States of America | – |
| US5902476A | Cites | United States of America | – |
| US6132616A | Cites | United States of America | – |
| US2001037968A1 | Cites | United States of America | – |
| US6635026B1 | Cites | United States of America | – |
| US7387734B2 | Cites | United States of America | – |
| JACOBS C. ET AL: 'Replacement of Renal Function by Dialysis', vol. 4, 1996, KLUWER ACADEMIC PUBLISHERS, DORDRECHT - BOSTON - LONDON pages 345 - 347 | Non-patent | – | – |
| 'Komplikationen der Dialysetechnik' JOURNAL FÜR DAS NEPHROLOGISCHE March 1988, page 95 | Non-patent | – | – |
| JACOBS C. ET AL: "Replacement of Renal Function by Dialysis", vol. 4, 1996, KLUWER ACADEMIC PUBLISHERS, DORDRECHT - BOSTON - LONDON, pages: 345 - 347 | Non-patent | – | Opposition |
| "Komplikationen der Dialysetechnik", JOURNAL FÜR DAS NEPHROLOGISCHE, March 1988 (1988-03-01), pages 95 | Non-patent | – | Opposition |
25 members in 11 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 0103907 | Sweden | A | |
| 0103907 | Sweden | A | |
| 0103907 | Sweden | – | |
| 0202145 | Sweden | W | |
| 0202145 | Sweden | W | |
| 0103907 | – | – | – |
| 2002002145 | – | – | – |
| SE20010003907 | – | – | – |
| WO2002SE02145 | – | – | – |
Members25
| Document | Office | Kind | |
|---|---|---|---|
| SE0103907D0 | Sweden | D0 | |
| SE0103907L | Sweden | L | |
| CA2461552A1 | Canada | A1 | |
| WO03043680A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2002348565A1 | Australia | A1 | |
| KR20040068149A | Republic of Korea | A | |
| EP1450879A1 | European Patent Office (EPO) | A1 | |
| SE525132C2 | Sweden | C2 | |
| US2005040110A1 | United States of America | A1 | |
| JP2005509497A | Japan | A | |
| US2006237351A1 | United States of America | A1 | |
| US7387734B2 | United States of America | B2 | |
| AT411060T | Austria | T | |
| ATE411060T1 | Austria | T1 | |
| EP1450879B1 | European Patent Office (EPO) | B1 | |
| DE60229428D1 | Germany | D1 | |
| ES2312636T3 | Spain | T3 | |
| JP4235555B2 | Japan | B2 | |
| KR20100086078A | Republic of Korea | A | |
| KR20100129797A | Republic of Korea | A | |
| KR101071800B1 | Republic of Korea | B1 | |
| CA2461552C | Canada | C | |
| KR101244119B1 | Republic of Korea | B1 | |
| EP1450879B2This record | European Patent Office (EPO) | B2 | |
| ES2312636T5 | Spain | T5 |
71 legal events, as 7 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Expiry of rightR071 | R071 | DE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Fee paymentPLFP | PLFP | FR | |
| Fee paymentPLFP | PLFP | FR | |
| Patent modifiedDC2A | DC2A | ES | |
| Patent maintained in amended form27A | 27A | EP | |
| Designated contracting statesAK | AK | EP | |
| Epo decision maintaining patent in amended form now finalR102 | R102 | DE | |
| Patent maintained in amended formORIGINAL CODE: 0009272PUAH | PUAH | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: PATENT MAINTAINED AS AMENDEDSTAA | STAA | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Appeal procedure closedAppealORIGINAL CODE: EPIDOSNNOA9OAPBU | APBU | EP | |
| Opposition filed (corrected)OppositionR26 | R26 | EP | |
| Opposition data, opponent's data or that of the opponent's representative modifiedOppositionORIGINAL CODE: 0009299OPPOPLAB | PLAB | EP | |
| Date of receipt of statement of grounds of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA3OAPBQ | APBQ | EP | |
| Appeal reference modifiedAppealORIGINAL CODE: EPIDOSCREFNOAPAH | APAH | EP | |
| Appeal reference recordedAppealORIGINAL CODE: EPIDOSNREFNOAPBM | APBM | EP | |
| Date of receipt of notice of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA2OAPBP | APBP | EP | |
| Communication despatched that patent is revokedRevokedORIGINAL CODE: EPIDOSNREV1RDAF | RDAF | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Reply of patent proprietor to notice(s) of opposition receivedOppositionORIGINAL CODE: EPIDOSNOBS3PLBB | PLBB | EP | |
| Information modified related to communication of a notice of opposition and request to file observations + time limitOppositionORIGINAL CODE: EPIDOSCOBS2PLAF | PLAF | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Opposition filedOpposition26 | 26 | EP | |
| Notice of opposition and request to file observation + time limit sentOppositionORIGINAL CODE: EPIDOSNOBS2PLAX | PLAX | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Opposition filedOppositionORIGINAL CODE: 0009260PLBI | PLBI | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)REGISTERED BETWEEN 20090528 AND 20090603732E | 732E | GB | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents actLapsedNLV1 | NLV1 | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| Corresponds to:REF | REF | EP | |
| Information provided on other rights and legal means of executionAT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR111Z | 111Z | EP | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| Designated contracting statesAK | AK | EP | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Title (correction)METHOD OF PRIMING A DIALYSIS MACHINERTI1 | RTI1 | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1450879
- Publication, DOCDB
- 1450879
- Publication, EPODOC
- EP1450879
- Application
- 27820661
- Application, DOCDB
- 02782066
- Application, EPODOC
- EP20020782066
Titles3
- German
- VERFAHREN ZUM INITIALISIEREN EINES DIALYSEGERÄTS
- English
- METHOD OF PRIMING A DIALYSIS MACHINE
- French
- PROCEDE POUR INITIALISER UN DIALYSEUR
Classification
- CPC, 9
- A61M1/168
- A61M1/1686
- A61M1/1656
- A61M1/1607
- A61M1/1666
- A61M1/1682
- A61M1/166
- A61M1/1668
- B01D61/28
- IPC, 2
- A61M1 16
- A61M1 14
Designated states1
- Contracting states, 1
- Türkiye